TAG ARCHIVES FOR research

15
Feb2013

by Julie Fine, Legal Specialist, Legal Division, Pfizer Inc. (Please note: The views presented here are my own and do not reflect positions or policies of Pfizer.)

In the weeks following the 2012 Advancing Ethical Research Conference, what has lingered with me most has been the keynote speech on mental illness and stigma by Elyn Saks, JD, PhD. She discussed how [...] Read more

12
Feb2013

by Anne Meade, Senior Manager for Website and Social Media

In early 2012, the IRB Forum, a resource-rich online community for human research protections professionals, found a new home at PRIM&R. We were (and are!) delighted to have this online community as a part of PRIM&R’s network of rich educational and networking resources.  The past year brought some changes to the [...] Read more

8
Feb2013

Punxsutawney Phil predicted that spring will come early this year, so to celebrate we’ve brought together the latest stories in the world of research ethics! In this Research Ethics Roundup installment, learn about burgeoning discussion of the use of placebos in developing countries, recent reports of government agencies funding redundant protocols, and much more!

Ethical controversy in human subjects research: The use of placebo as a control in clinical trials is typically considered unethical if an effective treatment for the condition under study already exists. However, in resource-scarce countries, individuals outside of clinical trials may not have access to those treatments. This blog post from Ruth [...] Read more

6
Feb2013

by Lesley Solomon, director of strategy and innovation at the Biomedical Research Institute at Brigham and Women’s Hospital, Boston

At Brigham and Women’s Hospital (BWH), we are constantly thinking about new ways to create conversations around our work—what it means to us, our patients and the community, and how we can strive to do better. It is in this spirit that we hosted our [...] Read more

8
Dec2012

by Julie Fine, BS, legal specialist, Legal Division, Worldwide Research and Development, Pfizer Inc. (Please note: The views presented here are my own and do not reflect the positions or policies of Pfizer Inc.)

On Thursday, I attended Challenges in Securing Coverage for Research-Related Injury, a session which was presented by my colleague, Marc D. Francis, JD, Pfizer Legal, and Karen E. Moe, PhD, University of Washington. Marc began by [...] Read more